Skip Navigation HRSA - Health Resources and Service Administration U.S. Department of Health & Human Services
Home
Questions
Order Publications
 
Grants Find Help Service Delivery Data Health System Concerns About HRSA

The HIV/AIDS Program: HAB Performance Measures Group 2

 

Syphilis Screening

 

< Previous | Home | Next >

On this page...
 
Performance Measure
 
Numerator
 
Denominator
 
Patient Exclusions
 
Data Element
 
Data Sources
 
National Goals, Targets or Benchmarks for Comparison
 
Outcome Measures for Consideration
 
Basis for Selection and Placement in Group 2
 
US Public Health Service Guidelines
 
References/Notes
 
Performance Measure: Syphilis Screening - OPR-Related Measure: Yes  

Percentage of adult clients with HIV infection who had a test for syphilis performed within the measurement year .

TOP
Numerator  

Number of HIV-infected clients who had a serologic test for syphilis performed at least once during the measurement year

TOP
Denominator  

Number of HIV-infected clients who:

  • were ≥ 18 years old in the measurement year [ 1 ] or had a history of sexual activity < 18 years, and
  • had a medical visit with a provider with prescribing privileges [ 2 ] at least once in the measurement year
TOP
Patient Exclusions  

Patients who were < 18 years old and denied a history of sexual activity

TOP
Data Elements  
  1. Is the client HIV-infected? (Y/N)
    1. If yes, is the client ≥ 18 years or reports having a history of sexual activity? (Y/N)
      1. If yes, was the client screened for syphilis during the measurement year?
TOP
Data Sources  
  • Ryan White Program Data Report, Section 5, Items 42 and 48 may provide data useful in establishing a baseline for this performance measure
  • Electronic Medical Record/Electronic Health Record
  • CAREWare, Lab Tracker, or other electronic data base
  • HIVQUAL reports on this measure for grantee under review
  • Medical record data abstraction by grantee of a sample of records
TOP
National Goals, Targets, or Benchmarks for Comparison 

IHI Goal: 90% [ 3 ]

National HIVQUAL Data4 ]
  2003 2004 2005 2006
Top 10%
99.0%
100.0%
100.0%
100.0%
Top 25%
90.4%
92.2%
95.7%
95.6%
Mean*
73.7%
78.5%
82.1%
80.0%

*from HAB data base

TOP
Outcome Measures for Consideration 

Incidence of neurosyphilis in the clinic population

TOP
Basis for Selection and Placement in Group 2 

HIV-1 infection appears to alter the diagnosis, natural history, management, and outcome of T. pallidum infection.

Measure reflects important aspect of care that impacts HIV-related morbidity and focuses on treatment decisions that affect a sizable population. Measure has a strong evidence base supporting the use.
TOP
US Public Health Service Guidelines 

"HIV-infected patients should be screened for behaviors associated with HIV transmission by using a straightforward, nonjudgmental approach. This should be done at the initial visit and subsequent routine visits or periodically, as the clinician feels necessary, but at a minimum of yearly. Any indication of risky behavior should prompt a more thorough assessment of HIV transmission risks. Screening for STDs should be repeated periodically (i.e., at least annually) if the patient is sexually active or if earlier screening revealed STDs. Screening should be done more frequently (e.g., at 3-6-month intervals) for asymptomatic persons at higher risk. [ 5 ] (7/18/03).

TOP
References/Notes 

[1] Onset of sexual activity is not reliably reported or recorded. The lower age bracket of 18 years is selected for performance measurement purposes only and should not be interpreted as a recommendation about the age at which screening should begin to occur.

[2] A "provider with prescribing privileges" is a health care professional who is certified in their jurisdiction to prescribe ARV therapy.

[3] IHI Measure reads, " Percent of Patients with Annual Syphilis Screen"
(http://www.ihi.org/IHI/Topics/HIVAIDS/HIVDiseaseGeneral/Measures/PercentofPatientswithAnnual
SyphilisScreen.htm
)

[4] http://www.hivguidelines.org/public_html/center/quality-of-care/hivqual-project/hivqual-workshop/03-04-natl-score-top10-25.pdf

[5] Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR 2003;52 (No. RR-12)
(http://aidsinfo.nih.gov/ContentFiles/HIVPreventionInMedCare_TB.pdf or http://aidsinfo.nih.gov/ContentFiles/HIVPreventionInMedCare_TB.pdf)

TOP